Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-018353

Options or other derivatives

  • Chief Operating Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cittadine Andrew Chief Operating Officer 2024-05-22 Grant or award · Stock Options +25,000 25,000 D
Loading xslF345X05/rdgdoc.xml…